MEDCLOVIR-500
Composition (Each vial contains):
Acyclovir (Sterile): 500 mg
Dosage Form: Lyophilized Powder for Injection
Therapeutic Class: Antiviral Agent
MEDCLOVIR-500 is an Acyclovir Injection in a lyophilized physical condition used in the treatment of severe viral infections that demand a parenteral antiviral agent. All the vials have 500mg of sterile Acyclovir, a viral replication inhibitor. Upon reconstitution, it should be under medical supervision to report the best systemic exposure. MEDCLOVIR -500 is particularly useful among hospitalized infected patients with severe herpesvirus infections, even when the immunity of a patient is weakened. Its highly specific antiviral effect alleviates the virus multiplication, severity of the disease, and accelerates clinical stabilization in intensive care and specialty care units.
MEDCLOVIR-500 is an Acyclovir Injection in a lyophilized physical condition used in the treatment of severe viral infections that demand a parenteral antiviral agent. All the vials have 500mg of sterile Acyclovir, a viral replication inhibitor. Upon reconstitution, it should be under medical supervision to report the best systemic exposure. MEDCLOVIR -500 is particularly useful among hospitalized infected patients with severe herpesvirus infections, even when the immunity of a patient is weakened. Its highly specific antiviral effect alleviates the virus multiplication, severity of the disease, and accelerates clinical stabilization in intensive care and specialty care units.
FAQ
Q: Why not oral therapy in the case of severe infections?
A: Injectable type of administration gives better and more stable blood levels in patients who cannot get their dose of medication properly through oral administration.
Q: How does Acyclovir specifically infect infected cells?
A: It is triggered on virus-infected cells mostly, which reduces their effect on uninfected healthy cells.
Q: Does MEDCLOVIR-500 work in viral infections of the central nervous system?
A: It is also typically utilized in viral encephalitis because it can achieve therapeutic CNS concentrations.
Q: Is early administration of Acyclovir beneficial?
A: The preventive treatment at a young age equally lowers the rate of viral reproduction, the severity of the disease, and the chances of complications.
Q: Is MEDCLOVIR-500 prophylaxis in high-risk patients effective?
A: It can be prophylactically employed in select immunocompromised patients with guidance from a specialist.
Q: Is renal functioning a factor that should impact the dosing of Acyclovir?
A: Yes, the dosage must be varied in patients with dysfunctional kidneys.
Q: Is injectable Acyclovir associated with viral resistance?
A: The resistance is rare yet possible during the lengthy treatment period, mostly among immunocompromised individuals.
Q: Why Acyclovir injection should be performed slowly?
A: Controlled infusion assists in decreasing the chances of kidney poisoning and infusion reactions.
FAQ
Apply for PCD Franchise – Not for Job Queries
Apply for PCD Franchise – Not for Job Queries
